What changed
$SOLV — WATCHLIST 📊
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States
🎯 Q2 2026 | Rev $2B | EPS $1.57 vs $1.50 🟢
💡 Consensus already priced in the beat; the variant view is that the beat does not signal sustained upside and the stock's low quantitative ranking (1st percentile) indicates structural headwinds.
📉 Reward/Risk: 1.0:1
🏢 Business Quality: 5/10 - Large health care company with stable operations but limited differentiation and recent spin-off challenges, leading to average quality.
📊 Valuation: fair - current P/E 9.9x appears low but is in line with its own limited history; the model's 0% expected 6m return suggests no mispricing.
📊 Our read: WATCHLIST. Full analysis →
https://stockduty.xyz/s/SOLV0623
Also in play: $V $MA $FIS $FISV $GPN $IBM
Why it matters
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States